Sionna Therapeutics (SION) Earnings Date & Reports

Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefit to CF patients... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

SION is expected to report earnings to rise 46.34% to -60 cents per share on December 03

Sionna Therapeutics SION Stock Earnings Reports

Q3'25

Est.

$-0.60

Q2'25

Beat

by $0.11

The last earnings report on August 11 showed earnings per share of -40 cents, beating the estimate of -51 cents. With 323.08K shares outstanding, the current market capitalization sits at 1.06B.

View a ticker or compare two or three

Compare

SION

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For SION
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. SION showed earnings on August 11, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details